Full Length Research Paper
References
|
Aaberg KM, Bakken IJ, Lossius MI, Lund-Søraas C, Håberg SE, Stoltenberg C, Suren P, Chin R (2016). Comorbidity and Childhood Epilepsy: A Nationwide Registry Study. Pediatrics 138(3): pii:e20160921. |
|
|
Al-Balaghee S, Al-Balaghee Z, Shabani A, Ghadam P, Bandehpour M, Askari Mehr A, Kazemi B (2015). Determination of haptoglobin genotype in an Iranian population with idiopathic generalized epilepsy. Rep. Biochem. Mol. Biol. 3(2):51-55. |
|
|
Anderson GD, Temkin NR, Dikmen SS, Diaz-Arrastia R, Machamer JE, Farhrenbruch C, Miller JW, Sadrzadeh SMH (2009). Haptoglobin Phenotype and Apolipoprotein E Polymorphism: Relationship to Post-Traumatic Seizures and Neuropsychological Functioning after Traumatic Brain Injury. Epilepsy Behav. 16(3):501-506. |
|
|
Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, Lejbkowicz F, Enav B, Shehadeh N, Kanter Y, Lache O, Cohen O, Levy NS, Levy AP. (2003). Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ. Res. 92(11):1193-200. |
|
|
Attilakos A, Papakonstantinou E, Schulpis K, Voudris K, Katsarou E, Mastroyianni S, Garoufi A (2006). Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Epilepsy Res. 71:229-232. |
|
|
Bernard DR, Langlois MR, Delanghe JR, De Buyzere ML (1997). Evolution of haptoglobin concentration in serum during the early phase of acute myocardial infarction. Euro. J. Clin. Chem. Clin. Biochem. 35(2):85-88. |
|
|
Conti M, Morand PC, Levillain P, Lemonnier A (1991). Improved Fluorometric. Clin. Chem. 37(7):1273-1275. |
|
|
Eiris JM, Lojo S, Del Rio MC, Novo I, Bravo M, Pavon P, Castro-Gago M (1995). Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. Neurology 45:1155-1157. |
|
|
Fall M, Toure K, Seck LB, Ndiaye M, Diop AG, Ndiaye MM (2015). Profil épidémiologique et prise en charge socioéconomique des patients vivant avec l'épilepsie à Dakar, Sénégal. La Tunisie Médicale. 93(2):101-103. |
|
|
Gogishvili AV, Kavtaradze, VG, Mamaladze GT, Arutiunova MS, Takadze GSH (1985). Haptoglobin phenotype distribution in patients at high risk of developing myocardial infarct. Kardiologiia 25(2):55-58. |
|
|
Guetta J, Strauss M, Levy NS, Fahoum L, Levy AP (2007). Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free haemoglobin. Atherosclerosis 191(1):48-53. |
|
|
Hamed SA, Hamed EA, Hamdy R, Nabeshima T (2007). Vascular risk factors and oxidative stress as independent predictors of asymptomatic atherosclerosis in adult patients with epilepsy. Epilepsy Res. 74:183-192. |
|
|
Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, Bamford JM, Markus HS (2004). Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 127:212-219. |
|
|
Hauser WA, Annegers JF, Kurland LT (1991). Prevalence of epilepsy in Rochester, Minnesota: 1940–1980. Epilepsia 32:429-445. |
|
|
Ilzecka J (1996). The biological role of haptoglobin and behaviour of this protein in different diseases, with special attention paid to brain stroke. Ann. Univ. Mariae Curie Sklodowska Med. 51:115-121. |
|
|
Isnard J, Guenot M, Ostrowsky K, Sindou M, Mauguiere F (2000). The role of the insular cortex in temporal lobe epilepsy. Ann. Neurol. 48(4):614-623. |
|
|
Isojärvi JI, Pakarinen AJ, Myllylä VV (1993). Serum lipid levels during carbamazepine medication. A prospective study. Arch. Neurol. 50:590-593. |
|
|
Kullo IJ, Ballantyne CM (2005). Conditional risk factors for atherosclerosis. Mayo Clin. Proc. 80:219-230. |
|
|
Langlois MR., Delanghe JR (1996). Biological and clinical significance of haptoglobin polymorphism in humans. Clin. Chem. 42(10):1589-1600. |
|
|
Levy AP, Hochberg I, Jablonski K, Resnick HE, Lee ET, Best L, Howard BV (2002). Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. J. Am. Coll. Cardiol. 40(11):1984-1990. |
|
|
Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K (2000). Haptoglobin phenotype and vascular complications in patients with diabetes. N. Engl. J. Med. 343:969-670. |
|
|
MacKellar M, Vigerust DJ (2016). Role of Haptoglobin in Health and Disease: A Focus on Diabetes. Clin. Diabetes 34:148-157. |
|
|
McCorry D, Chadwick D, Marson A (2004). Current drug treatment of epilepsy in adults. Lancet Neurol. 3:729-735. |
|
|
Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis RM (2001). Structure-function analysis of the antioxidant properties of haptoglobin. Blood 98(13):3693-3698. |
|
|
Moatti N. (2003). Athérosclérose : concepts actuels. In: Delattre J, Durand G, Jardillier JC. Biochimie pathologique: 83-90. Flammarion Médecine-Sciences, Paris, 2003. |
|
|
N'diaye S (2010). Les hallucinations dans les épilepsies partielles à propos de 31 cas Mémoire du CES de Neurologie. Université Cheikh Anta Diop, Dakar, n°331. |
|
|
Nakhoul FM, Zoabi R, Kanter Y, Zoabi M, Skorecki K, Hochberg I, Leibu R, Miller B, Levy AP (2001). Haptoglobin phenotype and diabetic nephropathy. Diabetologia 44(5):602-604. |
|
|
Ngoungou EB, Quet F, Dubreuil CM, Marin B, Houinato D, Nubukpo P, Dalmay F, Millogo A, Nsengiyumva G, Kouna-Ndouongo P, Diagana M, Ratsimbazafy V, Druet-Cabanac M, Preux PM (2006). Épidémiologie de l'épilepsie en Afrique subsaharienne : une revue de la littérature. Epilepsies 18(1):25-40. |
|
|
Nikolaos T, Stylianos G, Chryssoula N, Irini P, Christos M, Dimitrios T, Konstantinos P, Antonis T (2004). The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med. Sci. Monit. 10:MT50-MT52. |
|
|
Osuntokun BO, Adeuja AO, Nottidge VA (1987). Prevalence of the epilepsies in Nigerian Africans: a community-based study. Epilepsia 28:272-279. |
|
|
Osuntokun BO, Schoenberg BS, Nottidge VA, Adeuja A, Kale O, Adeyefa A, Bademosi O, Olumide A, Oyediran ABO, Pearson CA, Bolis CL (1982). Research protocol for measuring the prevalence of neurologic disorders in developing countries, results of pilot study in Nigeria. Neuroepidemiology 1(3):143-153. |
|
|
Panter SS, Sadrzadeh SM, Hallaway PE, Haines J, Anderson VE, Eaton JW (1984). Hypohaptoglobinemia: a possible predisposition to epilepsy. Trans. Assoc. Am. Physicians 97:56-62. |
|
|
Raymond S (1962). A convenient apparatus for vertical gel electrophoresis. Clin Chem. 8:455-470. |
|
|
Rwiza HT, Kilonzo GP, Haule J (1992). Prevalence and incidence of epilepsy in Ulanga, a rural Tanzanian District: A community-based study. Epilepsia 33:1051-1056. |
|
|
Saccucci P, Verdecchia M, Piciullo A, Bottini N, Rizzo R, Gloria-Bottini F, Lucarelli P, Curatolo P (2004). Convulsive disorder and genetic polymorphism. Association of idiopathic generalized epilepsy with haptoglobin polymorphism. Neurogenetics 5:245-248. |
|
|
Sadrzadeh SM, Saffari Y, Bozorgmehr J (2004). Haptoglobin phenotypes in epilepsy. Clin. Chem. 50:1095-1097. |
|
|
Schwaninger M, Ringleb P, Winter R, Kohl B, Fiehn W, Rieser PA, Walter-Sack I (1999). Elevated plasma concentrations of homocysteine in antiepileptic drug treatment. Epilepsia 40:345-350. |
|
|
Stocker R, Keaney JF Jr. (2004). Role of oxidative modifications in atherosclerosis. Physiol. Rev. 84:1381-1478. |
|
|
Tan TY, Lu CH, Chuang HY, Lin TK, Liou CW, Chang Wn, Chuang YC (2009). Long-term antiepileptic drug therapy contributes to the acceleration of atherosclerosis. Epilepsia 50(6):1579-1586. |
|
|
Tekle-Haimanot R, Forsgren L, Ekstedt J. (1997). Incidence of epilepsy in rural central Ethiopia. Epilepsia 38:541-546. |
|
|
Temple ME, Luzier AB, Kazierad DJ (2000). Homocysteine as a risk factor for atherosclerosis. Ann. Pharmacother. 34:57-65. |
|
|
Tseng CF, Lin CC, Huang HY, Liu HC, Mao SJ (2004). Antioxidant role of human haptoglobin. Proteomics 4:2221-2228. |
|
|
Tyagi N, Ovechkin AV, Lominadze D, Moshal KS, Tyagi SC (2006). Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. J. Cell. Biochem. 98:1150-1162. |
|
|
Yagi K (1976). A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15:212-216. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
